发明名称 Measurement of sleep apnea duration and evaluation of response therapies using duration metrics
摘要 An implantable cardiac device is programmed to detect an episode of sleep apnea, measure the duration of the episode, and store this information in memory. When multiple episodes are recorded, the device computes statistics on the apnea durations, such as average apnea duration and total apnea duration for a preselected time period (e.g., 8-hour rest period, 24-hour day, etc.). The implantable cardiac device may further be used to administer pacing therapy in response to detecting sleep apnea. Under the control of a physician, the implantable device may be programmed to administer different types of responsive therapies to evaluate whether certain therapies are more effective at treating apnea than others. For instance, a pacing therapy that results in lowering the average apnea duration or total apnea duration may be preferred over other pacing therapies that do not achieve such results.
申请公布号 US6881192(B1) 申请公布日期 2005.04.19
申请号 US20020170384 申请日期 2002.06.12
申请人 PACESETTER, INC. 发明人 PARK EULJOON
分类号 A61B5/00;A61B5/053;A61N1/365;(IPC1-7):A61B5/08 主分类号 A61B5/00
代理机构 代理人
主权项
地址